-
Newly Revised Drug Administration Law Adopted After Deliberation —To Comprehensively Implement the Four Strictest Requirements and Effectively Protect Drug Safety for the Public
2019-08-26
The remarkable results of pharmaceutical reforms and effective practices were transformed into laws to beef up rule of law for public health.
-
Provisions for In-vitro Diagnostic Reagent Registration (Abolished)
2019-07-25
The Provisions for In-vitro Diagnostic Reagent Registration, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.
-
Provisions for Supervision of Drug Distribution
2019-07-25
The Provisions for Supervision of Drug Distribution, adopted at the executive meeting of the State Food and Drug Administration on December 8, 2006, is hereby promulgated and shall go into effect as of May 1, 2007.
-
Provisions for Drug Registration (Abolished)
2019-07-25
The Provisions are formulated for the purposes of ensuring the safety, efficacy and quality of drugs and regulating drug registration in accordance with the Drug Administration Law of the People's Republic of China, Administrative Permission Law of the People's Republic of China and the Regulations for Implementation of the Drug Administration Law of the People's Republic of China.
-
Provisions for Drug Insert Sheets and Labels
2019-07-25
The Provisions for Drug Insert Sheets and Labels, adopted at the executive meeting of the State Food and Drug Administration on March 10, 2006, is hereby promulgated and shall go into effect as of June 1, 2006.
